Butanedioic acid en es it fr

Butanedioic acid Brand names, Butanedioic acid Analogs

Butanedioic acid Brand Names Mixture

  • No information avaliable

Butanedioic acid Chemical_Formula

C4H7N1O4

Butanedioic acid RX_link

No information avaliable

Butanedioic acid fda sheet

Butanedioic acid msds (material safety sheet)

http://domino.solutia.com/solutia/smsdslib.nsf/0/561ad1a8b4bae67c8625636000511152/$FILE/English.pdf

Butanedioic acid Synthesis Reference

No information avaliable

Butanedioic acid Molecular Weight

133.104 g/mol

Butanedioic acid Melting Point

230 oC

Butanedioic acid H2O Solubility

4.5 g/l

Butanedioic acid State

Solid

Butanedioic acid LogP

-0.67 +/- 0.36

Butanedioic acid Dosage Forms

Capsules and powder

Butanedioic acid Indication

There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.

Butanedioic acid Pharmacology

L-aspartate is considered a non-essential amino acid, meaning that, under normal physiological conditions, sufficient amounts of the amino acid are synthesized in the body to meet the body's requirements. L-aspartate is formed by the transamination of the Krebs cycle intermediate oxaloacetate. The amino acid serves as a precursor for synthesis of proteins, oligopeptides, purines, pyrimidines, nucleic acids and L-arginine. L-aspartate is a glycogenic amino acid, and it can also promote energy production via its metabolism in the Krebs cycle. These latter activities were the rationale for the claim that supplemental aspartate has an anti-fatigue effect on skeletal muscle, a claim that was never confirmed.

Butanedioic acid Absorption

Absorbed from the small intestine by an active transport process

Butanedioic acid side effects and Toxicity

Mild gastrointestinal side effects including diarrhea. LD50 (rat) > 5,000 mg/kg.

Butanedioic acid Patient Information

No information avaliable

Butanedioic acid Organisms Affected

Humans and other mammals